SLC5A2 and Parkinson disease: Here, in this review, we will discuss the involvement of mitochondrial related oxidative stress in the development of PD, the potential shared cellular mechanisms between T2DM and PD, and possible benefits provided by antidiabetic agents for disease modification of PD especially focusing on SGLT2 inhibitors.